Themes US Cash Flow Champions ETF(USCF.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Themes US Cash Flow Champions ETF
USCF.US
News
View More

BUZZ-Instacart falls as Kroger expands delivery with Uber

Shares of online grocery delivery platform Instacartdown 3.8% at $39.31Grocer Krogeradds nearly 2,700 stores on the Uber Eats, Uberand Postmates apps across the nation, as per its previously announced plans“The expanded partnership between Kroger and Uber offers some compelling incentives for shoppers that could draw them away from Instacart in the short term,” says Emarketer analyst Sky CanavesThough Instacart is the dominant player in the U.S. grocery intermediary space, it is losing share to Uber and Doordash, anaylst saysIn 2025, CART was up 3.6%

Reuters·
US
DASH
-2.28%
US
CART
-1.00%
US
KR
+1.12%
Reuters·
US
DASH
-2.28%
US
CART
-1.00%
US
KR
+1.12%

These Analysts Revise Their Forecasts On Wells Fargo Following Q4 Earnings

Wells Fargo & Company (NYSE:WFC) reported stronger-than-expected Q4 earnings, with net income of $5.4 billion, or $1.62 per diluted share, surpassing last year's $5.1 billion. Adjusted earnings of $1.76 beat the consensus of $1.67, while revenue rose 4% to $21.3 billion. Analysts revised their price targets post-earnings: Truist's John McDonald lowered his target from $104 to $100, Argus's Stephen Biggar raised his from $94 to $101, and Evercore's John Pancari lowered his from $110 to $105. Wells Fargo shares fell 0.3% to $88.95.

benzinga_article·
US
WFC
-0.65%
benzinga_article·
US
WFC
-0.65%

AbbVie plans to build out its presence in obesity market

AbbVie is expanding its presence in the obesity treatment market by leveraging Gubra's weight-loss drug, GUBamy, which mimics the hormone amylin. This drug aims to provide an alternative to GLP-1 drugs like Wegovy and Zepbound, focusing on better tolerability and durability of weight loss. AbbVie believes its existing aesthetics business positions it well, as patients seeking cosmetic treatments are also interested in weight loss solutions. The obesity drug market is projected to reach $150 billion in annual sales within the next decade.

Reuters·
US
ABBV
-0.31%
Reuters·
US
ABBV
-0.31%

Wells Fargo Enters Its First Post-Asset-Cap Earnings Test: Here's Why Q4 Results Could Redefine The Bank's Growth Story

Wells Fargo is set to report its Q4 earnings, marking the first significant test of its strategy following the removal of an asset cap that had restricted its growth since 2018. The bank aims to increase its return on tangible common equity (ROTCE) to 17-18% and has set a new common equity tier 1 target of 10.0-10.5%. Analysts remain optimistic, with a "Buy" rating and a price target increase to $107, indicating a potential upside. Wells Fargo's stock is currently trading at 13.59 times forward earnings, lower than the S&P 500 average.

benzinga_article·
US
WFC
-0.65%
benzinga_article·
US
WFC
-0.65%

Buy The Dip In JPMorgan Or Delta Air Lines Stock After Q4 Earnings?

JPMorgan and Delta Air Lines reported positive Q4 earnings but saw stock declines of over 2% due to cautious economic outlooks. JPMorgan's Q4 sales rose 7% to $45.79 billion, with net income at $13 billion, while Delta's sales increased 3% to $16 billion, with net income at $1.22 billion. Both companies face challenges, including geopolitical tensions and inflation concerns. Analysts suggest that despite the cautious outlook, the stocks may be attractively valued, making them potential buy opportunities post-earnings selloff.

Talkmarkets·
US
DAL
-1.28%
US
JPM
+1.04%
Talkmarkets·
US
DAL
-1.28%
US
JPM
+1.04%
© 2026 Longbridge｜Disclaimer